From Medscape Pulmonary Medicine

Coverage from the

European Respiratory Society (ERS) 2019 International Congress

September 28 - October 02, 2019; Madrid, Spain

September 28 - October 02, 2019 Madrid, Spain

Conference News

Popular News From ERS 2018

  • First-in-Class COPD Drug Eases Symptoms First-in-Class COPD Drug Eases Symptoms An inhaled PDE3/4 inhibitor could serve as an add-on to standard treatments for patients with stubborn symptoms and exacerbations of chronic obstructive pulmonary disease, investigators report.
  • For Stubborn COPD, Airway Ablation Bolsters Drug Effects For Stubborn COPD, Airway Ablation Bolsters Drug Effects Targeted lung denervation appears to maximize the benefits of the anticholinergic drugs often prescribed to patients with chronic obstructive pulmonary disease (COPD), new research shows.
  • Long-term Benralizumab Safe and Effective for Severe Asthma Long-term Benralizumab Safe and Effective for Severe Asthma The drug is safe for severe uncontrolled asthma over 2 years, and reduces exacerbations in vast majority of patients, according to results from the 1-year BORA extension study.

Medscape Pulmonary Medicine© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Previous Coverage